Related Experiment Video
Updated: May 16, 2025

07:42
A Data-Driven Approach to Quantifying Immune States in Sepsis
Published on: February 7, 2025
123
A multicenter study on developing a prognostic model for severe fever with thrombocytopenia syndrome using machine
Jian-She Xu1, Kai Yang2, Bin Quan3
1School of Public Health, Nanjing Medical University, Nanjing, China.
Frontiers in Microbiology
|April 3, 2025
Summary
A new machine learning model accurately predicts outcomes for Severe Fever with Thrombocytopenia Syndrome (SFTS). This interpretable XGBoost model uses 7 key features to aid early prognosis and clinical decision-making for SFTS patients.
Area of Science:
- Infectious Diseases
- Machine Learning
- Medical Informatics
Background:
- Severe Fever with Thrombocytopenia Syndrome (SFTS) is a serious viral illness caused by the SFTS virus (SFTSV).
- Accurate prognosis is vital for tailoring SFTS prevention and treatment strategies.
- Existing machine learning prognostic models for SFTS require further development and clinical validation.
Purpose of the Study:
- To develop and validate an interpretable machine learning (ML) prognostic model for SFTS.
- To improve the understanding of SFTS disease progression through ML.
Main Methods:
- A multicenter retrospective study analyzed data from 292 patients for training/internal validation and 104 patients for external validation.
- The Boruta algorithm identified 12 candidate predictors from 24 clinical features, with 10 ML models developed.
- Model performance was evaluated using AUC, accuracy, recall, F1 score, and SHAP for feature importance.
Main Results:
- The XGBoost model exhibited the best discriminatory performance.
- A final interpretable XGBoost model with 7 key features achieved high predictive accuracy (Internal AUC: 0.911, External AUC: 0.891).
- A clinical decision support tool was developed using the Streamlit framework.
Conclusions:
- An interpretable XGBoost-based prognostic model for SFTS demonstrates high predictive accuracy.
- The model's 7 key features provide valuable indicators for early SFTS prognosis.
- The developed clinical tool supports healthcare professionals in managing SFTS.

